Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.
Intravenous immunoglobulin (IVIG) is donor-derived antibodies used in myasthenia gravis (MG) for fast symptom control. It’s used for flares, maintenance, bridging slower therapies, or pre-surgery ...
Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...
Monthly IVIG reduced grade ≥2 infections from 100% pre-treatment to 33% post-treatment, yielding a 67% relative and absolute risk reduction with strong statistical significance. Baseline IgG and IgA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results